REGULATORY AFFAIRS

Biocompatibility assessment

Biocompatibility assessment plays a crucial role in the overall design and development process. It ensures that device materials and design do not lead to adverse reactions when in contact with the human body. Given the intricate nature of immune responses, strategic planning is essential for assessing biocompatibility in medical devices. Understanding how each device component interacts and the potential implications is critical for patient safety and regulatory compliance.

Biocompatibility assessment

Our experts offer comprehensive, customized support—from planning to test execution. Our approach prioritizes risk assessment, aiming to identify and mitigate potential risks to ensure that your products are biocompatible and safe to use. We collaborate closely with you to understand your medical device’s specific requirements and develop tailored strategies to address them effectively, including:

Identification of applicable standards and requirements related to target markets.
Characterization of the materials used in the medical device.
Risk Assessment of potential biological hazards associated with the intended use of the device.
Planning and outlining the specific tests, test methods, acceptance criteria, sample sizes and testing facilities.
Analyzing and evaluating data to assess the overall biocompatibility of the device.
Implementing a post-market surveillance plan to monitor the biocompatibility of your medical device once it is on the market.

Whether you’re a startup looking for comprehensive regulatory assistance or an established company seeking to enhance your compliance strategy, we’re here to support you every step of the way.

Regulatory plans

Regulatory plans for medical device manufacturers.

Technical Documentation

All medical devices must have a set of documentation available to support its compliance to applicable regulations. Aurevia supports you in planning and creating the needed Technical Documentation.

Electrical Safety IEC 60601

IEC 60601-1 is the basic international safety standard for medical electrical devices and systems.

Biological Safety ISO 10993

International standard of biological safety evaluation process and preparing biological evaluation documentation for medical device manufacturers.

IVDR compliance for in-house developed tests

Laboratories developing IVDs in-house must maintain Technical Documentation and Quality Management Systems to comply with the IVDR and the national law.

IVD Performance Evaluation

In vitro diagnostic medical device (IVD) regulations are set out in the EU In Vitro Diagnostics Regulation.

Qualification and classification of medical devices

Our team’s versatile experience and the available tools help in bringing clarity to the challenging cases.

Medical software

Adhering to medical device software regulations throughout the entire lifecycle.

Risk Management ISO 14971

Setting up and implementing a risk management system and preparing risk management documentation.

Aurevia appoints Jonna Pelanti as the new Head of EQA business area

We are delighted to announce the appointment of the new Head of the EQA business area Jonna Pelanti.

Meet us at BioMedica in Dublin

Meet us at the BioMedica exhibition at booth A18!

Aurevia appoints Ulrika Hammarström as the new Head of CRO business area

We are delighted to announce the appointment of the new Head of the CRO business area Ulrika Hammarström.

Introducing the EQA Pilot Studies 2025

Aurevia appoints Anna-Karin Alm as the new Head of the QA/RA business area

Anna-Karin Alm assumes the QA/RA business area head position in Aurevia and will lead the Aurevia QA/RA organization in...

Biocompatibility assessment